GP in many parts of England are having explain to eligible patients that tirzepatide (Mounjaro) cannot be prescribed in ...

The once-monthly drug is still under study but could provide added convenience and another option for patients.

Viking Therapeutics ( VKTX -4.27%) soared early last year when it reported strong data from the phase 2 trial of its weight ...

GLP-1 drugs are revolutionizing the treatment of obesity and diabetes. Here's what to know about investing in GLP-1 stocks.

A major change in the rules starts on Monday and you must have four medical conditions as well as a specific BMI ...

Toby Nicol, CEO at CheqUp, said: “We welcome the NHS making Mounjaro available, but the reality is that it will remain out of ...

Around 1.5 million Brits are now taking weight-loss drugs, such as Mounjaro, and pharmacists are warning users to be careful in the heatwave ...

LORRAINE Kelly made an emotional confession on her show this morning as she opened up about weight loss and body image.

Tirzepatide has already been approved for treating obesity in Scotland by the Scottish Medicines Consortium for people with a BMI above 30kg/m² and one weight related condition. NHS Scotland are ...

It's estimated that around 1.5 million Brits are now taking weight-loss drugs, with numbers increasing each week. The last year has seen a huge increase in the number of people taking GLP-1 receptor ...

Prescriptions for tirzepatide injections will not be available from GP surgeries or pharmacies in East and North Yorkshire – ...